Scholarlink

<p>Gestational weight gain (GWG) is a critical determinant of maternal and neonatal health, with both excess (EGWG) and inadequate GWG (IGWG) linked to adverse pregnancy outcomes and metabolic risk. We investigated the association between maternal prenatal demographic, clinical, and metabolic biomarkers at baseline, and GWG in singleton pregnancies from the Early Tracking of Childhood Health Determinants (ETCHED) life-course cohort. GWG, defined as the difference between pregestational and pre-delivery weight, was the primary outcome. Among 120 eligible mothers, 79.2% self-identified as Hispanic and 16.0% as American Indian/Alaska Native. The cohort represented socioeconomically disadvantaged populations: 75% had a high school education or less, 31% were single mothers, and 52.5% reported an annual household income &lt; $25,000. Compared with mothers with normal GWG, those with EGWG had significantly higher leptin and lower IL-8 levels (<i>P</i> &lt; 0.05). A multivariate multinomial logistic regression identified leptin to be strongly associated with EGWG (OR/1 SD: 11.09; 95%CI 3.18–38.67; <i>P</i> = 0.001), followed by FGF21, IL8, and pregestational BMI. Higher cortisol levels were associated with increased risk of IGWG (OR/1 SD: 2.59; 95%CI 1.07–6.29; <i>P</i> = 0.03). EGWG was associated with higher rates of cesarean delivery and prematurity. These findings highlight distinct metabolic and inflammatory biomarkers associated with GWG in an understudied population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Association between gestational weight gain and metabolic and inflammatory biomarkers in the ETCHED cohort

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月25日

查看全文
  • Sourav RoyChoudhury,
  • Rachel Caballero,
  • Dorota Wasak,
  • Yunhua L. Muller,
  • Zaqueena Coleman,
  • William C. Knowler,
  • Robert L. Hanson,
  • Marilyn Q. Sale,
  • Madhumita Sinha

摘要

Gestational weight gain (GWG) is a critical determinant of maternal and neonatal health, with both excess (EGWG) and inadequate GWG (IGWG) linked to adverse pregnancy outcomes and metabolic risk. We investigated the association between maternal prenatal demographic, clinical, and metabolic biomarkers at baseline, and GWG in singleton pregnancies from the Early Tracking of Childhood Health Determinants (ETCHED) life-course cohort. GWG, defined as the difference between pregestational and pre-delivery weight, was the primary outcome. Among 120 eligible mothers, 79.2% self-identified as Hispanic and 16.0% as American Indian/Alaska Native. The cohort represented socioeconomically disadvantaged populations: 75% had a high school education or less, 31% were single mothers, and 52.5% reported an annual household income < $25,000. Compared with mothers with normal GWG, those with EGWG had significantly higher leptin and lower IL-8 levels (P < 0.05). A multivariate multinomial logistic regression identified leptin to be strongly associated with EGWG (OR/1 SD: 11.09; 95%CI 3.18–38.67; P = 0.001), followed by FGF21, IL8, and pregestational BMI. Higher cortisol levels were associated with increased risk of IGWG (OR/1 SD: 2.59; 95%CI 1.07–6.29; P = 0.03). EGWG was associated with higher rates of cesarean delivery and prematurity. These findings highlight distinct metabolic and inflammatory biomarkers associated with GWG in an understudied population.